Co-Target(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T15068 | Target Info | |||
Target Name | Focal adhesion kinase 1 (FAK) | ||||
Synonyms |
pp125FAK; p125FAK; Protein-tyrosine kinase 2; Protein phosphatase 1 regulatory subunit 71; PPP1R71; Focal adhesion kinase-related nonkinase; FRNK; FAK1; FADK 1; FADK
Click to Show/Hide
|
||||
Target Type | Clinical trial Target | ||||
Gene Name | PTK2 | ||||
Biochemical Class | Kinase | ||||
UniProt ID |
Co-Targets of This Target | Top | |||||
---|---|---|---|---|---|---|
Co-Target Name | ALK tyrosine kinase receptor (ALK) | Successful Target | ||||
UniProt ID | ALK_HUMAN | |||||
Gene Name | ALK | |||||
Synonyms |
CD246; Anaplastic lymphoma kinase
Click to Show/Hide
|
|||||
Representative Drug(s) | CEP-37440 | Drug Info | IC50 = 3.1 nM | [1] | ||
Co-Target Name | Insulin receptor (INSR) | Successful Target | ||||
UniProt ID | INSR_HUMAN | |||||
Gene Name | INSR | |||||
Synonyms |
IR; CD220 antigen; CD220
Click to Show/Hide
|
|||||
Representative Drug(s) | CEP-37440 | Drug Info | IC50 = 65 nM | [1] | ||
Co-Target Name | Stress-activated protein kinase JNK2 (JNK2) | Patented-recorded Target | ||||
UniProt ID | MK09_HUMAN | |||||
Gene Name | MAPK9 | |||||
Synonyms |
Stress-activated protein kinase 1a; SAPK1a; PRKM9; Mitogen-activated protein kinase 9; Mitogen-activated protein kinase 8-interacting protein 2; MAPK 9; MAP kinase 9; Jun-N-terminal kinase 2; JNK-interacting protein 2; JNK-55; JNK MAP kinase scaffold protein 2; JIP-2; Islet-brain-2; IB-2; C-jun-amino-terminal kinase interacting protein 2; C-Jun N-terminal kinase 2
Click to Show/Hide
|
|||||
Representative Drug(s) | VS-4718 | Drug Info | IC50 = 120 nM | [2] | ||
Co-Target Name | Stress-activated protein kinase JNK3 (JNK3) | Patented-recorded Target | ||||
UniProt ID | MK10_HUMAN | |||||
Gene Name | MAPK10 | |||||
Synonyms |
Stress-activated protein kinase 1b; SAPK1b; PRKM10; Mitogen-activated protein kinase 10; MAPK 10; MAP kinase p49 3F12; MAP kinase 10; JNK3A; C-Jun N-terminal kinase 3
Click to Show/Hide
|
|||||
Representative Drug(s) | VS-4718 | Drug Info | IC50 = 160 nM | [2] | ||
Co-Target Name | Focal adhesion kinase 2 (PTK2B) | Literature-reported Target | ||||
UniProt ID | FAK2_HUMAN | |||||
Gene Name | PTK2B | |||||
Synonyms |
Related adhesion focal tyrosine kinase; RAFTK; Protein-tyrosine kinase 2-beta; Proline-rich tyrosine kinase 2; PYK2; FAK2; FADK 2; Cell adhesion kinase beta; Calcium-regulated non-receptor proline-rich tyrosine kinase; Calcium-dependent tyrosine kinase; CAKB; CAK-beta; CADTK
Click to Show/Hide
|
|||||
Representative Drug(s) | PF-562271 | Drug Info | IC50 = 13 nM | [3] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Discovery of Clinical Candidate CEP-37440, a Selective Inhibitor of Focal Adhesion Kinase (FAK) and Anaplastic Lymphoma Kinase (ALK). J Med Chem. 2016 Aug 25;59(16):7478-96. | ||||
REF 2 | Synthesis and SAR of 2,4-diaminopyrimidines as potent c-jun N-terminal kinase inhibitors. Medchemcomm. 2012;3:238-43. | ||||
REF 3 | Selectivity switch between FAK and Pyk2: Macrocyclization of FAK inhibitors improves Pyk2 potency. Bioorg Med Chem Lett. 2016 Dec 15;26(24):5926-30. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.